Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.50 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.41 |
| ▸ | PRKDC | P78527 | 12/20 | 0.41 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.39 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.38 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21578701 | 0.95 | ALOX5 (0.50) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL24936634 | 0.95 | ALOX5 (0.54) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL1687786 | 0.94 | ALOX5 (0.48) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL1687753 | 0.94 | ALOX5 (0.48) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL1687807 | 0.94 | ALOX5 (0.48) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL1687739 | 0.94 | ALOX5 (0.50) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL15294176 | 0.93 | ALOX5 (0.48) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL21578704 | 0.93 | ALOX5 (0.48) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL17885403 | 0.93 | ALOX5 (0.48) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL22672105 | 0.93 | ALOX5 (0.48) | ALOX5GGPS1PRKDCPTGES2PRMT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9401482-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-07-26 | — | — | US | disclosed |
| US-9401482-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-07-26 | — | — | US | disclosed |
| US-20160028021-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-01-28 | — | — | US | disclosed |
| EP-2966706-A2 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2016-01-13 | — | — | EP | disclosed |
| US-20150097176-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-04-09 | — | — | US | disclosed |
| US-20150097176-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-04-09 | — | — | US | disclosed |
| US-8932734-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2015-01-13 | — | — | US | disclosed |
| US-8932734-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2015-01-13 | — | — | US | disclosed |
| WO-2012048266-A1 | NOVEL 3, 9-LINKED OLIGOCARBAZOLE-BASED HOSTS, CONTAINING DBT AND DBR FRAGMENTS, SEPARATED BY AROMATIC SPACERS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-04-12 | — | — | WO | disclosed |
| US-20120086329-A1 | Novel 3, 9-Linked Oliogocarbazole-Based Hosts, Containing DBT and DBF Fragments, Separated by Aromatic Spacers | Universal Disolay Corporation (US) | 2012-04-12 | — | — | US | disclosed |
| US-20120086329-A1 | Novel 3, 9-Linked Oliogocarbazole-Based Hosts, Containing DBT and DBF Fragments, Separated by Aromatic Spacers | Universal Disolay Corporation (US) | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120086329-A1 | Novel 3, 9-Linked Oliogocarbazole-Based Hosts, Containing DBT and DBF Fragments, Separated by Aromatic Spacers | DBF4, OGFOD1, DDT | ALOX5 1460/4885GGPS1 404/4885PRKDC 2338/4885 |
| US-20160028021-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OR10J3 | ALOX5 336/4885GGPS1 1495/4885PRKDC 4297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.